0001655808-18-000001.txt : 20180427 0001655808-18-000001.hdr.sgml : 20180427 20180427150546 ACCESSION NUMBER: 0001655808-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180427 DATE AS OF CHANGE: 20180427 EFFECTIVENESS DATE: 20180427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SeqOnce BioSciences, Inc. CENTRAL INDEX KEY: 0001655808 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-311199 FILM NUMBER: 18783231 BUSINESS ADDRESS: STREET 1: 2265 E. FOOTHILL BOULEVARD CITY: PASADENA STATE: CA ZIP: 91107 BUSINESS PHONE: 626-765-3894 MAIL ADDRESS: STREET 1: 2265 E. FOOTHILL BOULEVARD CITY: PASADENA STATE: CA ZIP: 91107 D 1 primary_doc.xml X0708 D LIVE 0001655808 SeqOnce BioSciences, Inc. 2265 E. FOOTHILL BOULEVARD PASADENA CA CALIFORNIA 91107 626-765-3894 DELAWARE SeqOnce BioSciences, LLC None Corporation true 2015 Christopher Angermayer c/o SeqOnce BioSciences, Inc. 2265 E. Foothill Blvd. Pasadena CA CALIFORNIA 91107 Executive Officer Director Joseph Dunham c/o SeqOnce BioSciences, Inc. 2265 E. Foothill Blvd. Pasadena CA CALIFORNIA 91107 Director Michael Giardello c/o SeqOnce BioSciences, Inc. 2265 E. Foothill Blvd. Pasadena CA CALIFORNIA 91107 Director Biotechnology Decline to Disclose 06b false 2018-04-20 false true true false 0 1220911 1010909 210002 $508,913.17 in conversion of promissory notes; $339,997.36 in new money; $161,998.68 in warrants to purchase stock false 12 0 0 0 false SeqOnce BioSciences, Inc. /s/ Christopher Angermayer Christopher Angermayer Chief Executive Officer 2018-04-26